The following new psychoactive substances shall be subjected to control measures across the Union:
(a)
4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4′-DMAR);
(b)
1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45).
資料由法律人 LawPlayer整理提供·EU law / curated by LawPlayer from EUR-Lex
The following new psychoactive substances shall be subjected to control measures across the Union:
(a)
4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4′-DMAR);
(b)
1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45).
By 21 October 2016, Member States shall take the necessary measures, in accordance with their national law, to subject the new psychoactive substances referred to in Article 1 to control measures and criminal penalties, as provided for under their legislation complying with their obligations under the 1961 United Nations Single Convention on Narcotic Drugs and/or under the 1971 United Nations Convention on Psychotropic Substances.
This Decision shall enter into force on the day following that of its publication in the Official Journal of the European Union.
This Decision shall apply in accordance with the Treaties.
Council Implementing Decision (EU) 2015/1873 of 8 October 2015 on subjecting 4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4′-DMAR) and 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45) to control measures (EUR-Lex). Retrieved via LawPlayer, https://lawplayer.com/eu/act/32015D1873
© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.
本頁資料來源:EUR-Lex·整理提供:法律人 LawPlayer· lawplayer.com